Which is the best alternative treatment for cancer?
Talk to your doctor if you’re interested in trying: 1 Acupuncture. During acupuncture treatment, a practitioner inserts tiny needles into your skin… 2 Aromatherapy. Aromatherapy uses fragrant oils to provide a calming sensation. 3 Exercise. Exercise may help you manage signs and symptoms during and after cancer treatment.
What kind of cancer can be treated with mebendazole?
Indeed, Mebendazole, alone or combined with chemo, has been shown to be effective against multiple forms of cancer cells, such as: adrenal cancer (Ref.1, Ref.2) colon cancer (Ref.1, Ref.2) brain cancer, medulloblastoma, glioblastoma (Ref.1, Ref.2, Ref.3, Ref.4) melanoma (Ref.1, Ref.2, Ref.3)
When did atezolizumab get approved for SCLC?
In March 2019, the Food and Drug Administration approved the immunotherapy drug atezolizumab (Tecentriq) in combination with standard chemotherapy for the initial treatment of advanced SCLC, based on results from a trial reported in September 2018.
Are there any anti cancer drugs on the market?
Mebendazole, a well-known anti-helminthic drug in wide clinical use, has anti-cancer properties that have been elucidated in a broad range of pre-clinical studies across a number of different cancer types. Significantly, there are also two case reports of anti-cancer activity in humans.
Which is better carmustine or berberine for cancer?
Berberine in culture or in rats given cancer tumours, on its own produced a 91% kill rate in cell cultures, compared to 43% for carmustine. When the two were combined the kill rate rose to 97% (Zhang, RX et al, 1990).
Is there an alternative to metformin for cancer treatment?
Although it is generally well tolerated, berberine can cause constipation, which usually clears up over time or with a reduction in dosage. Berberine (or its’ whole plant extracts) may be an alternative anti-cancer compound to metformin, as it shares many of the same mechanisms of action.
How is berberine used to treat brain tumours?
Berberine enhanced the activity of carmustine, a chemo drug often used on brain tumours. Berberine in culture or in rats given cancer tumours, on its own produced a 91% kill rate in cell cultures, compared to 43% for carmustine. When the two were combined the kill rate rose to 97% (Zhang, RX et al, 1990).